Randomised controlled trials and real-life studies: two answers for one question
Sergio Harari
Eur Respir Rev, 27 (149) 180080; 10.1183/16000617.0080-2018 |    |
Bronchiectasis: a case-based approach to investigation and management
Martina Contarini, Simon Finch, James D. Chalmers
Eur Respir Rev, 27 (149) 180016; 10.1183/16000617.0016-2018 | |
Systematic review of drug effects in humans and models with surfactant-processing disease
Dymph Klay, Thijs W. Hoffman, Ankie M. Harmsze, Jan C. Grutters, Coline H.M. van Moorsel
Eur Respir Rev, 27 (149) 170135; 10.1183/16000617.0135-2017 | |
Cardiovascular disease and COPD: dangerous liaisons?
Klaus F. Rabe, John R. Hurst, Samy Suissa
Eur Respir Rev, 27 (149) 180057; 10.1183/16000617.0057-2018 | |
How long is too long? A scoping review of health system delays in lung cancer
Ashanya Malalasekera, Sharon Nahm, Prunella L. Blinman, Steven C. Kao, Haryana M. Dhillon, Janette L. Vardy
Eur Respir Rev, 27 (149) 180045; 10.1183/16000617.0045-2018 | |
The broad spectrum of lung diseases in primary antibody deficiencies
Francesco Cinetto, Riccardo Scarpa, Marcello Rattazzi, Carlo Agostini
Eur Respir Rev, 27 (149) 180019; 10.1183/16000617.0019-2018 | |
Noninvasive ventilation in acute respiratory failure: which recipe for success?
Raffaele Scala, Lara Pisani
Eur Respir Rev, 27 (149) 180029; 10.1183/16000617.0029-2018 | |
Precision medicine in COPD: where are we and where do we need to go?
Venkataramana K. Sidhaye, Kristine Nishida, Fernando J. Martinez
Eur Respir Rev, 27 (149) 180022; 10.1183/16000617.0022-2018 | |
Pulmonary hypertension associated with neurofibromatosis type 1
Etienne-Marie Jutant, Barbara Girerd, Xavier Jaïs, Laurent Savale, Caroline O'Connell, Frederic Perros, Olivier Sitbon, Marc Humbert, David Montani
Eur Respir Rev, 27 (149) 180053; 10.1183/16000617.0053-2018 | |
Cadmium lung adsorption, citrullination and an enhanced risk of COPD
David Hutchinson
Eur Respir Rev, 27 (149) 180054; 10.1183/16000617.0054-2018 | |